BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37527682)

  • 1. Genomic alterations associated with rapid progression of brain metastases.
    Uggerly ASV; Cummins DD; Nguyen MP; Saggi S; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Daras M; Aghi MK; Morshed RA
    Neurosurg Focus; 2023 Aug; 55(2):E15. PubMed ID: 37527682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
    Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
    Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor progression in patients receiving adjuvant whole-brain radiotherapy vs localized radiotherapy after surgical resection of brain metastases.
    Hsieh J; Elson P; Otvos B; Rose J; Loftus C; Rahmathulla G; Angelov L; Barnett GH; Weil RJ; Vogelbaum MA
    Neurosurgery; 2015 Apr; 76(4):411-20. PubMed ID: 25599198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
    Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
    J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
    J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resection followed by stereotactic radiosurgery to resection cavity for intracranial metastases.
    Do L; Pezner R; Radany E; Liu A; Staud C; Badie B
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):486-91. PubMed ID: 18922650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracranial relapse rates and patterns, and survival trends following post-resection cavity radiosurgery for patients with single intracranial metastases.
    Ogiwara H; Kalakota K; Rakhra SS; Helenowski IB; Marymont MH; Kalapurakal JA; Mehta MP; Levy RB; Chandler JP
    J Neurooncol; 2012 May; 108(1):141-6. PubMed ID: 22426925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative stereotactic radiosurgery without whole-brain radiation therapy for brain metastases: potential role of preoperative tumor size.
    Hartford AC; Paravati AJ; Spire WJ; Li Z; Jarvis LA; Fadul CE; Rhodes CH; Erkmen K; Friedman J; Gladstone DJ; Hug EB; Roberts DW; Simmons NE
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):650-5. PubMed ID: 22795806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor bed radiosurgery after resection of cerebral metastases.
    Mathieu D; Kondziolka D; Flickinger JC; Fortin D; Kenny B; Michaud K; Mongia S; Niranjan A; Lunsford LD
    Neurosurgery; 2008 Apr; 62(4):817-23; discussion 823-4. PubMed ID: 18414136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of additional brain metastases on the day of stereotactic radiosurgery: risk factors and outcomes.
    Garcia MA; Lazar A; Duriseti S; Raleigh DR; Hess CP; Fogh SE; Barani IJ; Nakamura JL; Larson DA; Theodosopoulos P; McDermott M; Sneed PK; Braunstein S
    J Neurosurg; 2017 Jun; 126(6):1756-1763. PubMed ID: 27367235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and recent advances in resection cavity irradiation of brain metastases.
    Minniti G; Niyazi M; Andratschke N; Guckenberger M; Palmer JD; Shih HA; Lo SS; Soltys S; Russo I; Brown PD; Belka C
    Radiat Oncol; 2021 Apr; 16(1):73. PubMed ID: 33858474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery of the postoperative resection cavity for brain metastases: prospective evaluation of target margin on tumor control.
    Choi CY; Chang SD; Gibbs IC; Adler JR; Harsh GR; Lieberson RE; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):336-42. PubMed ID: 22652105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosurgery for intracranial hemangiopericytomas: outcomes after initial and repeat Gamma Knife surgery.
    Olson C; Yen CP; Schlesinger D; Sheehan J
    J Neurosurg; 2010 Jan; 112(1):133-9. PubMed ID: 19392594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of salvage surgery for local progression of brain metastasis previously treated with stereotactic irradiation: diagnostic contribution, functional outcome, and prognostic factors.
    Mitsuya K; Nakasu Y; Hayashi N; Deguchi S; Oishi T; Sugino T; Yasui K; Ogawa H; Onoe T; Asakura H; Harada H
    BMC Cancer; 2020 Apr; 20(1):331. PubMed ID: 32303195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Brain Metastasis Genomic Alterations with Preoperative Imaging Features.
    Uggerly ASV; Cummins DD; Nguyen MP; Saggi S; Aghi MK; Morshed RA
    World Neurosurg; 2024 Jan; 181():e475-e482. PubMed ID: 37879437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Stereotactic Radiotherapy of the Resection Cavity After Surgery of Brain Metastases Compared to Postoperative Whole-Brain Radiotherapy (ESTRON)-A Single-Center Prospective Randomized Trial.
    El Shafie RA; Paul A; Bernhardt D; Hauswald H; Welzel T; Sprave T; Hommertgen A; Krisam J; Schmitt D; Klüter S; Schubert K; Klose C; Kieser M; Debus J; Rieken S
    Neurosurgery; 2018 Sep; 83(3):566-573. PubMed ID: 29528419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.
    Morshed RA; Nguyen MP; Cummins DD; Saggi S; Young JS; Haddad AF; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Hervey-Jumper SL; Daras M; Aghi MK
    Neurooncol Adv; 2023; 5(1):vdad007. PubMed ID: 36915611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic radiosurgery for post operative brain metastasic surgical cavities: a single institution experience.
    Cantaloube M; Boucekine M; Balossier A; Muracciole X; Meyer M; Delsanti C; Carron R; Beltaifa YM; Figarella-Branger D; Regis J; Padovani L
    Radiat Oncol; 2022 Sep; 17(1):160. PubMed ID: 36163026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic alterations associated with postoperative nodular leptomeningeal disease after resection of brain metastases.
    Morshed RA; Cummins DD; Nguyen MP; Saggi S; Vasudevan HN; Braunstein SE; Goldschmidt E; Chang EF; McDermott MW; Berger MS; Theodosopoulos PV; Daras M; Hervey-Jumper SL; Aghi MK
    J Neurosurg; 2024 Feb; 140(2):328-337. PubMed ID: 37548547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.